文献速递乳腺癌放疗放疗物理与技术

eIF4A抑制剂silvestrol增强T-47D导管乳腺癌细胞对外照射放疗的敏感性

The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapy.
PubMed 文献 · Clin Transl Radiat Oncol · 2020-07-24

该体外研究以T-47D导管乳腺癌细胞为模型,探讨eIF4A抑制剂silvestrol能否增强外照射放疗的敏感性。结果显示,照射前或照射后持续使用1 nM silvestrol可显著降低细胞活力,克隆形成实验的剂量修饰因子为1.4,提示低浓度silvestrol增敏放疗且对未照射细胞影响较小。

要点

  • 照射前1 nM silvestrol使2 Gy照射后细胞活力降低34%(p=0.014)。
  • 照射后持续1 nM silvestrol六天使2 Gy照射后活力降低58%(p<0.001)。
  • 克隆形成实验剂量修饰因子为1.4(p<0.001),提示放疗增敏。

核心结论

  • 低浓度silvestrol可增敏T-47D乳腺癌细胞对放疗的反应,且对未照射细胞影响较小。

研究设计与样本

  • 体外细胞研究,以T-47D导管乳腺癌细胞为模型,使用0 nM至1 nM silvestrol处理,照射0 Gy至10 Gy(直线加速器),通过MTT活力和克隆形成实验评估反应。

主要发现

  • 照射前1 nM silvestrol处理使2 Gy照射后细胞活力较DMSO对照降低34%(p=0.014)。
  • 照射后持续1 nM silvestrol六天使2 Gy照射后肿瘤细胞活力降低58%(p<0.001)。
  • 克隆形成实验显示持续1 nM silvestrol的剂量修饰因子为1.4(p<0.001,单因素方差分析)。

临床怎么用

  • 提示eIF4A抑制可能作为放疗增敏策略,在肿瘤部位增强辐射损伤而不引起全身毒性。

局限性

  • 研究仅为体外细胞实验,结果需进一步体内验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: eIF4A is an RNA helicase that forms part of the machinery of translation initiation.Proteomic analysis demonstrated eIF4A expression to be at least two-fold greater in a radioresistant derivative of T-47D breast cancer cells compared to parental cells.Inhibition of eIF4A has previously been shown to re-sensitize lymphomas to chemotherapeutic agents that cause DNA damage.The objective of this work is to investigate whether inhibition of eIF4A using silvestrol sensitizes breast cancer cells to radiotherapy in tissue culture, using T-47D as a model system. METHODS AND MATERIALS: T-47D cells were incubated in medium containing 0 nM to 1 nM silvestrol either for 24 h prior to irradiation at 0 Gy to 10 Gy, delivered by linear accelerator (LINAC) or continually for six days post irradiation. MTT viability and clonogenic assays were used to quantify response. RESULTS: Pre-treatment of T-47D cells with 1 nM silvestrol caused a 34% reduction (p = 0.014) in viability on irradiation at 2 Gy compared to treatment with a DMSO control, as assessed by MTT assay.Maintenance of cells in 1 nM silvestrol for six days following irradiation at 2 Gy caused a 58% reduction (p = <0.001) in tumor cell viability.Clonogenic assays performed on cells maintained in 1 nM silvestrol following irradiation showed a dose modifying factor (DMF) of 1.4 (p = <0.001, one-way ANOVA). CONCLUSIONS: Low concentrations of silvestrol sensitize T-47D breast cancer cells to radiation with minimal effects on unirradiated cells. This highlights the possible usefulness of eIF4A inhibition in potentiating radiation-induced damage at the tumor site without causing systemic toxicity.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Webb TE, Davies M, Maher J, et al. The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapy. Clin Transl Radiat Oncol. 2020. PMID: 32875125. doi:10.1016/j.ctro.2020.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。